Find your next paid study

Stefanie Sarantopoulos, MD, PhD.NCT06233110

~$150 – $4,500

Actual pay is set by the research site.

Phase 1

A Phase I First-in-human Clinical Trial to Evaluate the Safety, Pharmacokinetics, and Antiviral Activity of the Broadly Neutralizing Antibody BNT351 in Adults Living Without and With HIV

This study will test the safety and blood levels of the antibody BNT351 in people living without and with human immunodeficiency virus (HIV). This study will a…

HIV -1 Infection

Cystic Fibrosis Related Diabetes

~$500 – $11,250

Actual pay is set by the research site.

BioNTech SENCT07392372

Genetic Modifiers of Cystic Fibrosis Related Diabetes

This research is being done to find the genes and other factors that are responsible for differences among persons with cystic fibrosis. We are particularly in…

Johns Hopkins UniversityNCT01113216

Actual pay is set by the research site.

PARCA (a Digital Tool) to Improve Justice and Health

The purpose of this study is to assess the effectiveness of the Probation/Parole and Reentry Coach Application (PARCA)-a mobile application that allows justice…

Behavioral Addiction

George Mason UniversityNCT07199374

Actual pay is set by the research site.

Pacing TherapyPostoperative CarePediatric Congenital Heart Surgery+2 more

Postoperative Pacing for Cardiac Efficiency

The goal of this study is to determine whether temporarily increasing a child's heart rate after heart surgery can improve blood flow and oxygen supply to the …

Robert G. Webster, MD, MPHNCT07852390

~$10 – $1,125

Actual pay is set by the research site.

The Fundamentals of Communication in Surgery (FCS): A Pilot Study to Evaluate the Scalability and Impact of A Clinical Communication Curriculum

The goal of this observational study is to evaluate the impact of the FCS curriculum on achieving the learning objectives and resident reported self-efficacy w…

Communication ResearchCommunication Programs

University of Wisconsin, MadisonNCT06654310

Actual pay is set by the research site.

Acute Myeloid LeukemiaB Acute Lymphoblastic LeukemiaB Lymphoblastic Lymphoma+1 more

Red Blood Cell Transfusion Threshold-Specific Bleeding, Quality of Life and Functional Outcomes in Acute Leukemia Patients With Thrombocytopenia: a Randomized Feasibility Study

This clinical trial evaluates the effects of hemoglobin threshold-specific packed red blood cell (PRBC) transfusions on quality of life and functional outcomes…

University of WashingtonNCT06710418

Actual pay is set by the research site.

Phase 2

A Phase 2 Study of Emapalumab for Prevention of Liver Failure in Pediatric Indeterminate Severe Hepatitis Associated With T-Cell Activation: Severe Hepatitis Intervention With Emapalumab for Liver Disease

The goal of this study is to see whether a medicine called emapalumab, a monoclonal antibody, is safe and works well for patients aged 1 year and older who hav…

Hepatitis

Children's Healthcare of AtlantaNCT07744919

~$75 – $3,000

Actual pay is set by the research site.

Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer

The goal of this study is to find the best way to help participants and families manage the stress of facing a serious illness and be better able to "bounce ba…

StressAnxiety

Dana-Farber Cancer InstituteNCT06038318

~$10 – $1,125

Actual pay is set by the research site.

Phase 1

Metformin and Muscle Recovery Following ACL Surgery

The purpose of this research study is to determine if Metformin taken after anterior cruciate ligament reconstruction (ACLR) surgery can decrease muscle fibros…

AtrophyInflammationWeakness, Muscle

University of UtahNCT07699367

~$150 – $3,000

Actual pay is set by the research site.

Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy [SUpplemental Patient dMd assessMents Investigating ouTcomes (SUMMIT)]

The goal of this study is to collect additional information on the safety of long-term treatment with AGAMREE® and to explore long-term clinical impact of AGAM…

Duchenne Muscular Dystrophy

Catalyst Pharmaceuticals, Inc.NCT06564974

~$10 – $1,050

Actual pay is set by the research site.

Phase 1

A Phase 1b/2a, Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Activity of Small Mobile Stem Cells (SMS) Delivered Into the Lung as a Potential Organ Regeneration Therapy in Moderate to Severe Chronic Obstructive Pulmonary Disease (SORT-COPD Study II)

This study is a phase 1b/2a, open-label, non-randomized, observation of 125 adults, with moderate to severe chronic obstructive pulmonary disease, treated with…

Chronic Obstructive Lung Disease